Tuesday, February 26, 2019

Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

WhatsApp Reportedly Issues Fix for Chat Syncing Issue With Linked Devices

WhatsApp is reportedly implementing a security fix to address the issue where a user's chats across devices were not synced properly. Th...